Forrest

This Week in Biotech
Motley Fool
Sun, 08/18/13 - 11:58 am
Osiris Therapeutics
Inovio
GSK
Gilead Sciences
Forrest
Almirall
Theravance
MannKind
This Week in Biotech
Motley Fool
Sun, 07/28/13 - 11:13 am
Array Biopharma
Biocryst
Forrest
Vertex Pharmaceuticals
Teva
Forest Laboratories, Inc. Announces Settlement Agreement with Hetero Labs Ltd. in BYSTOLIC® Patent Litigation
Business Wire
Sat, 10/27/12 - 12:25 pm
Forrest
Hetero Labs
Bystolic
generics
patents
lawsuits
Forest and Almirall Report Preliminary Topline Results from the ACCORD COPD II Phase III Study of aclidinium bromide in Chronic Obstructive Pulmonary Disease (COPD)
Pipeline Review
Sun, 10/31/10 - 11:02 am
Forrest
Almirall
COPD
aclidinium bromide
Forest Labs' Reward to Risk Ratio Hits the Spot
Seeking Alpha
Sun, 04/25/10 - 11:37 am
Forrest
Forest Laboratories Receives Decision From FDA For Supplemental New Drug Application For Bystolic(R)
Medical News Today
Sat, 02/27/10 - 12:44 pm
Forrest
Bystolic
heart failure
Forest's Promising COPD Candidate
Yahoo/Zacks
Sat, 01/23/10 - 10:54 am
Forrest
aclidinium
COPD